MOTRIN PLATINUM MUSCLE & BODY 200 MG — DIN 02418967
IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is MOTRIN PLATINUM MUSCLE & BODY?
MOTRIN PLATINUM MUSCLE & BODY 200 MG contains IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02418967, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Feb-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MOTRIN PLATINUM MUSCLE & BODY used for?
Effective relief of pain associated with muscle spasm such as back pain, tense neck muscles, strains and sprains.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Methocarbamol, Combinations Excl Psycholeptics in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Methocarbamol, Combinations Excl Psycholeptics, across 68 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| VITA HEALTH PRODUCTS INC | 9 | 6 | EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA, MUSCLE & BACK PAIN ASA 325 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 325 MG, MUSCLE & BACK PAIN RELIEF CAPLETS, +4 more | Sourceable in Canada |
| HALEON CANADA ULC | 4 | 4 | ROBAX PLATINUM, ROBAXACET, ROBAXACET EXTRA STRENGTH, ROBAXISAL EXTRA STRENGTH | Sourceable in Canada |
| MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 5 | 3 | EXTRA STRENGTH TYLENOL BACK PAIN, EXTRA STRENGTH TYLENOL BODY PAIN NIGHT, MOTRIN PLATINUM MUSCLE & BODY, REGULAR STRENGTH TYLENOL BACK PAIN, REGULAR STRENGTH TYLENOL BODY PAIN NIGHT | Sourceable in Canada |
| TEVA CANADA LIMITED | 9 | 0 | ANALGESIC AND MUSCLE RELAXANT CAPLETS, AXUM, METHOXACET, METHOXACET EXTRA STRENGTH, METHOXISAL EXTRA STRENGTH, +4 more | No marketed DIN |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 8 | 0 | MUSCLE & BACK PAIN RELIEF, MUSCLE & BACK PAIN RELIEF EXTRA STRENGTH, MUSCLE AND BACK PAIN RELIEF, MUSCLE AND BACK PAIN RELIEF EXTRA STRENGTH, SUMMIT ULTRA | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 7 | 0 | A.S.A. WITH METHOCARBAMOL NIGHT-TIME EXTRA STRENGTH, EXTRA STRENGTH BACK PAIN, EXTRA STRENGTH BODY PAIN NIGHT, EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF, MUSCLE AND BACK PAIN RELIEF REGULAR STRENGTH TABLETS, +2 more | No marketed DIN |
| BAYER INC CONSUMER CARE | 3 | 0 | ASPIRIN NIGHT-TIME, EXTRA STRENGTH ASPIRIN BACKACHE, MIDOL NIGHT-TIME | No marketed DIN |
| MARCAN PHARMACEUTICALS INC | 3 | 0 | ACETAMINOPHEN 325MG + METHOCARBAMOL 400MG CAPLETS, ACETAMINOPHEN 500MG + METHOCARBAMOL 400MG EXTRA STRENGTH CAPLETS, IBUPROFEN+METHOCARBAMOL CAPLETS | No marketed DIN |
| TECHNILAB PHARMA INC. | 3 | 0 | MUSCLE AND BACK PAIN RELIEF WITH ASA, MUSCLE AND BACK PAIN RELIEF WITH ASA EXTRA STRENGTH, MUSCLE RELAXANT AND ANALGESIC | No marketed DIN |
| WYETH CONSUMER HEALTHCARE INC. | 3 | 0 | ROBAXACET TABLETS, ROBAXISAL CAPLETS, ROBAXISAL TABLETS | No marketed DIN |
| BAYER INC | 2 | 0 | ASPIRIN BACKACHE, SUPER EXTRA STRENGTH ASPIRIN BACKACHE | No marketed DIN |
| STELLA PHARMACEUTICAL CANADA INC. | 2 | 0 | DODD'S BACK-EASE MUSCLE SPASM AND BACK PAIN RELIEF, DODD'S EXTRA STRENGTH BACK-EASE | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Blisters of 18 and bottles of 40 caplets. |
| Storage | Not explicitly stated in provided text (Section 11 referenced but content not shown). Typical for this class is 15-30°C. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Methocarbamol, Combinations Excl Psycholeptics |
|---|---|
| ATC code | M03BA53 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02418967 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2418967 |
| Brand name | MOTRIN PLATINUM MUSCLE & BODY |
| Generic / active ingredient | IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG |
| Market authorization holder | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M03BA53 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M03BA |
| Current status | MARKETED |
| Status date | 26-Feb-2026 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults and Children over 12: 1 to 2 caplets every 4-6 hours. Do not exceed 6 caplets in 24 hours unless recommended by a physician. Use lowest effective dose for shortest duration.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ingredients; active peptic ulcer/GI disease; severe hepatic/renal impairment; asthma/allergic reactions to ASA/NSAIDs; SLE; third trimester pregnancy; peri-operative heart surgery.
Warnings and precautions
Serious GI toxicity (bleeding/ulceration); increased risk of CV thrombotic events (MI/stroke); fluid retention/edema; potential for drowsiness/dizziness; risk of aseptic meningitis in SLE.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 68 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG | 400 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02252228 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02239141 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02426625 |
| EXTRA STRENGTH TYLENOL BACK PAIN | 400 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02290510 |
| EXTRA STRENGTH TYLENOL BODY PAIN NIGHT | 500 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | 02357356 |
| MUSCLE & BACK PAIN RELIEF CAPLETS | 325 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02230790 |
| MUSCLE AND BACK PAIN PLATINUM RELIEF | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02422042 |
| MUSCLE AND BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | 02451298 |
| ROBAX PLATINUM | 500 MG | TABLET | HALEON CANADA ULC | MARKETED | 02247147 |
| ROBAXACET | 325 MG | TABLET | HALEON CANADA ULC | MARKETED | 02026805 |
2 · Same class — other molecules in ATC M03BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Methocarbamol, Combinations Excl Psycholeptics | A.S.A. WITH METHOCARBAMOL NIGHT-TIME EXTRA STRENGTH · ACETAMINOPHEN 325MG + METHOCARBAMOL 400MG CAPLETS · ACETAMINOPHEN 500MG + METHOCARBAMOL 400MG EXTRA STRENGTH CAPLETS · ADVIL BACK PAIN · +54 more | 68 | 13 | Yes |
| Methocarbamol | METHOCARBAMOL INJ 100MG/ML · METHOCARBAMOL OMEGA · PMS-METHOCARBAMOL INJ 100MG/ML · ROBAXIMOL INJ 100MG/ML · +4 more | 8 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M03B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M03BX | Baclofen · Cyclobenzaprine · Tizanidine | 87 | 35 |
| M03BC | Orphenadrine (Citrate) · Orphenadrine, Combinations | 7 | 1 |
| M03BB | Chlorzoxazone, Combinations Excl Psycholeptics | 8 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.